Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Other Working Capital Changes (2016 - 2025)

Anika Therapeutics (ANIK) has disclosed Other Working Capital Changes for 16 consecutive years, with -$1.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Working Capital Changes fell 2327.78% to -$1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.3 million, a 317.03% decrease, with the full-year FY2025 number at -$2.3 million, down 317.03% from a year prior.
  • Other Working Capital Changes was -$1.3 million for Q4 2025 at Anika Therapeutics, down from -$219000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.8 million in Q4 2022 to a low of -$2.0 million in Q3 2022.
  • A 5-year average of -$213950.0 and a median of -$74500.0 in 2021 define the central range for Other Working Capital Changes.
  • Peak YoY movement for Other Working Capital Changes: surged 1466.67% in 2022, then plummeted 2327.78% in 2025.
  • Anika Therapeutics' Other Working Capital Changes stood at $238000.0 in 2021, then soared by 675.63% to $1.8 million in 2022, then crashed by 86.02% to $258000.0 in 2023, then plummeted by 120.93% to -$54000.0 in 2024, then tumbled by 2327.78% to -$1.3 million in 2025.
  • Per Business Quant, the three most recent readings for ANIK's Other Working Capital Changes are -$1.3 million (Q4 2025), -$219000.0 (Q3 2025), and -$1.0 million (Q2 2025).